Table 2. Laboratory Findings in Biotin and Control Groups.
Outcome variable | Control (n=35) | Biotin (n=35) |
p value Mean Df±srd(CI 95%) |
---|---|---|---|
HgA1c (%) | |||
Baseline | 9.39±1.58 | 9.84±1.80 | 0.290 |
After 3 mo. | 10.11±1.68 | 8.88±1.73 | |
p value | <0.001 | <0.001 | <0.001 |
Mean Df±srd(CI 95%) | -0.714±0.049(-0.906,-0.523) | 0.959±0.142(0.672,1.247) | 1.673±0.170(1.334,2.014) |
FBS (mg/dl) | |||
Baseline | 274.85±74.40 | 275.91±65.76 | 0.823 |
After 3 mo. | 276.47±50.67 | 226±41.31 | |
p value | 0.818 | <0.001 | <0.001 |
Mean Df±srd (CI 95%) | -1.617±6.988(-15.834,12.599) | 49.914±6.495(36.71,63.11) | 50.987±6.786(-25.845,67.910) |
Chol (mg/dl) | |||
Baseline | 149.18±22.54 | 149.69±23.56 | 0.928 |
After 3 mo. | 156.07±18.77 | 148.6±21.09 | |
p value | 0.004 | 0.449 | 0.002 |
Mean Df±srd(CI 95%) | -6.893±2.201(-11.409,-2.377) | 1.095±1.434(-1.800,3.991) | -7.999±2.510(-12.998,-2.977) |
TG (mg/dl) | |||
Baseline | 100.18±16.61 | 96.48±36.20 | 0.565 |
After 3 mo. | 103.86±14.69 | 90.43±27.54 | |
p value | 0.025 | 0.055 | 0.017 |
Mean Df± srd(CI 95%) | -3.679±1.552(-6.862,-0.495) | 6.048±3.063(-0.138,-12.234) | 9.726±3.957(1.810,17.642) |
LDL (mg/dl) | |||
Baseline | 74.25±8.39 | 75.69±10.71 | 0.551 |
After 3 mo. | 76.64±7.95 | 73.12±8.90 | |
p value | 0.019 | 0 .016 | 0.001 |
Mean Df±srd(CI 95%) | -2.393±0.963(-4.368,-0.418) | 2.571±1.028(0.496,4.647) | 4.964±1.484(2.001,7.927) |
HDL (mg/dl) | |||
Baseline | 42.57±4.19 | 43.38±5.57 | 0.515 |
After 3 mo. | 41.54±3.74 | 42.64±5.01 | |
p value | 0.002 | 0.235 | 0.666 |
Mean Df±srd(CI 95%) | 1.036±0.311(0.398,1.673) | 0.738±0.613(-0.499,1.975) | -0.298±0.793(-1.881,1.286) |
TG: triglyceride; Chol: cholesterol; HDL: high density lipoprotein cholesterol; LDL: low density lipoprotein cholesterol; Mean Df: Mean Difference; srd: Std. Error Difference; CI: Confidence Interval of the Difference